Funder: Novo Nordisk
Due Dates: April 28, 2025 (Call opens) | October 8, 2025 (Call closes)
Funding Amounts: DKK 40–75 million (approx. EUR 5.4–10 million) per grant; up to 6 years duration
Summary: Funds ambitious research consortia to develop innovative models of human cardiometabolic disease, advancing translational and collaborative science.
Key Information: Consortium must include at least one Danish research group; industry partners may collaborate but cannot receive funding.